Dr. Taylor J. Hess, DO
Neurology (Neurology Physician)
- Medicare participating
At a glance
- Years since graduation
- 8
- In the NPI registry since
- 2018
- Medicare patients seen, 2024
- 76
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. What an NPI is
Education and training
- 2018Registered with an NPI (national billing number; not a license date)
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Neurology Physician primary
MI license 5151012051
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Beaumont Hospital, Troy Troy, MI
- Henry Ford Macomb Hospital Clinton Township, MI
- Beaumont Hospital - Grosse Pointe Grosse Pointe, MI
- Henry Ford Health St John Hospital Detroit, MI
Medical groups
- Glendale Neurological Associates P C (40 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 76
- Services billed
- 11,072
- Patients’ average age
- 63
| Service | Times | Patients |
|---|---|---|
| Established patient office or other outpatient visit, 30-39 minutes | 27 | 24 |
| Established patient office or other outpatient visit, 40-54 minutes | 16 | 13 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Gabapentin Other prescribers in Roseville, MI | 54 |
| Dalfampridine Er (dalfampridine) | 19 |
| Dextroamphetamine-Amphet Er (dextroamphetamine/amphetamine) Other prescribers in Roseville, MI | 19 |
| Donepezil Hcl Other prescribers in Roseville, MI | 19 |
| Levetiracetam Other prescribers in Roseville, MI | 19 |
| Divalproex Sodium Other prescribers in Roseville, MI | 18 |
| Tizanidine Hcl Other prescribers in Roseville, MI | 18 |
| Baclofen Other prescribers in Roseville, MI | 16 |
| Ubrelvy (ubrogepant) Other prescribers in Roseville, MI | 14 |
| Myrbetriq (mirabegron) Other prescribers in Roseville, MI | 13 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 7 companies reported 30 payments worth $25,030 in total to this clinician.
| Biogen, Inc. | $10,267 |
|---|---|
| Genzyme Corporation | $7,088 |
| EMD Serono, Inc. | $3,754 |
| Amgen Inc. | $2,852 |
| Tg Therapeutics, Inc. | $756 |
| Novartis Pharmaceuticals Corporation | $295 |
| Boston Scientific Corporation | $19.39 |
| Compensation for services other than consulting (speaking, faculty) | $16,170 |
|---|---|
| Consulting Fee | $7,656 |
| Food and Beverage | $1,088 |
| Education | $116 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Genzyme Corporation Nov 18, 2025 | Compensation for services other than consulting (speaking, faculty) | $3,432 |
| Genzyme Corporation May 1, 2025 | Compensation for services other than consulting (speaking, faculty) | $3,432 |
| Biogen, Inc. Sep 10, 2025 | Compensation for services other than consulting (speaking, faculty) TYSABRI · Neurology | $2,961 |
| Amgen Inc. Jun 3, 2025 | Consulting Fee UPLIZNA · Inflammation/Rare Disease | $2,750 |
| Biogen, Inc. Jun 19, 2025 | Compensation for services other than consulting (speaking, faculty) VUMERITY · Neurology | $2,538 |
| Biogen, Inc. Aug 15, 2025 | Compensation for services other than consulting (speaking, faculty) TYSABRI · Neurology | $2,538 |
| Biogen, Inc. Apr 4, 2025 | Compensation for services other than consulting (speaking, faculty) VUMERITY · Neurology | $1,269 |
| EMD Serono, Inc. Aug 12, 2025 | Consulting FeeCompany’s descriptionConsulting Services (Fee For Service) | $1,200 |
| EMD Serono, Inc. Aug 19, 2025 | Consulting FeeCompany’s descriptionConsulting Services (Fee For Service) | $1,200 |
| EMD Serono, Inc. Nov 25, 2025 | Consulting FeeCompany’s descriptionConsulting Services (Fee For Service) | $1,200 |
All 16 payments other than meals, newest first
| Company | What it was for | Amount |
|---|---|---|
| EMD Serono, Inc. Nov 25, 2025 | Consulting FeeCompany’s descriptionConsulting Services (Fee For Service) | $1,200 |
| Genzyme Corporation Nov 18, 2025 | Compensation for services other than consulting (speaking, faculty) | $3,432 |
| EMD Serono, Inc. Sep 23, 2025 | Education in-kind Company’s descriptionReprints | $57.98 |
| EMD Serono, Inc. Sep 23, 2025 | Education in-kind Company’s descriptionReprints | $57.98 |
| Biogen, Inc. Sep 10, 2025 | Compensation for services other than consulting (speaking, faculty) TYSABRI · Neurology | $2,961 |
| EMD Serono, Inc. Aug 19, 2025 | Consulting FeeCompany’s descriptionConsulting Services (Fee For Service) | $1,200 |
| Biogen, Inc. Aug 15, 2025 | Compensation for services other than consulting (speaking, faculty) TYSABRI · Neurology | $2,538 |
| EMD Serono, Inc. Aug 12, 2025 | Consulting FeeCompany’s descriptionConsulting Services (Fee For Service) | $1,200 |
| Biogen, Inc. Aug 11, 2025 | Consulting Fee TYSABRI · Neurology | $212 |
| Biogen, Inc. Aug 4, 2025 | Consulting Fee VUMERITY · Neurology | $423 |
| Biogen, Inc. Jun 19, 2025 | Compensation for services other than consulting (speaking, faculty) VUMERITY · Neurology | $2,538 |
| Amgen Inc. Jun 3, 2025 | Consulting Fee UPLIZNA · Inflammation/Rare Disease | $2,750 |
| Tg Therapeutics, Inc. May 23, 2025 | Consulting Fee BRIUMVI · Immunology | $565 |
| Genzyme Corporation May 1, 2025 | Compensation for services other than consulting (speaking, faculty) | $3,432 |
| Biogen, Inc. Apr 4, 2025 | Compensation for services other than consulting (speaking, faculty) VUMERITY · Neurology | $1,269 |
| Biogen, Inc. Jan 2, 2025 | Consulting Fee | $106 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 2 industry-funded studies in 2025, from 2 companies. The companies reported $8,179 in research payments for these studies, mostly to the institutions running them.
- (ENABLE) REal world experieNce with BRIUMVI (ublituximAB-xiiy) treated patients: a Longitudinal rEgistry study
Tg Therapeutics, Inc. - A Randomized, Open-label, Parallel-group, Non-inferiority Study Comparing Efficacy, Safety, and Tolerability of Remibrutinib After Switching From Ocrelizumab in Participants Living With Relapsing Multiple Sclerosis, F…
Novartis Pharmaceuticals Corporation
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.